A Synopsis of the Clinical Uses of Argatroban
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 12 (2) , 141-149
- https://doi.org/10.1023/a:1012919404290
Abstract
Argatroban, a direct thrombin inhibitor, has been used in Japan since the early 1980's and was recently approved for use in the United States for patients with heparin-induced thrombocytopenia....Keywords
This publication has 39 references indexed in Scilit:
- The First Report of Successful Carotid Stent Implant Using Argatroban Anticoagulation in a Patient with Heparin-Induced Thrombocytopenia and Thrombosis SyndromeAngiology, 1998
- Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin InhibitorSeminars in Thrombosis and Hemostasis, 1997
- Effect of the Thrombin Inhibitor Argatroban in Acute Cerebral ThrombosisSeminars in Thrombosis and Hemostasis, 1997
- The human pharmacology of thrombin inhibitionCoronary Artery Disease, 1996
- Novel antithrombotic approaches to coronary artery diseaseThe American Journal of Cardiology, 1995
- Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their PathogenesisSeminars in Thrombosis and Hemostasis, 1995
- Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonistsPharmacological Research, 1993
- Clinical Application of the Synthetic Thrombin Inhibitor, Argatroban (MD-805)Seminars in Thrombosis and Hemostasis, 1992
- Importance of antithrombin therapy during coronary angioplastyJournal of the American College of Cardiology, 1991
- Choice of anticoagulant in a congenital antithrombin III (AT III)-deficient patient with chronic renal failure undergoing regular haemodialysisClinical and Laboratory Haematology, 1989